• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
POH
Click for more information
0.00% 0.0¢

PROGRESS 2023-2 TRUST - Announcements

Market Cap $0  ! watchlist Created with Sketch. Add to my watchlist

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW

Filter Results
All Price Sensitive Only
search Created with Sketch. Search
search Created with Sketch. Search
Filters [Clear]
  • Price Sensitive: Yes
POH Changes to Leadership TeamPRICE SENSITIVE27/03/19
POH Appendix 4E - Preliminary Final ReportPRICE SENSITIVE28/02/19
POH FDA meeting provides guidance for TPM/Oxymorphone patchPRICE SENSITIVE17/01/19
POH Reinstatement to Offical QuotationPRICE SENSITIVE19/12/18
POH Phosphagenics and Mylan Agree SettlementPRICE SENSITIVE19/12/18
POH Suspension from Official QuotationPRICE SENSITIVE12/12/18
POH Trading HaltPRICE SENSITIVE10/12/18
POH Phosphagenics Arbitration Award IssuedPRICE SENSITIVE12/11/18
POH Receipt of R&D Tax IncentivePRICE SENSITIVE08/11/18
POH Response to ASX Price QueryPRICE SENSITIVE26/10/18
POH Phosphagenics Receives Further Arbitration Process UpdatePRICE SENSITIVE23/10/18
POH Phosphagenics Licensing Agreement UpdatePRICE SENSITIVE10/09/18
POH Half Year AccountsPRICE SENSITIVE13/08/18
POH AGM Chairman's Address and CEO PresentationPRICE SENSITIVE25/05/18 download Created with Sketch. 720.65KB
POH Terumo Shifts Focus From Oxymorphone Patch to InjectablesPRICE SENSITIVE20/03/18
POH Preliminary Final ReportPRICE SENSITIVE28/02/18
POH Phosphagenics Placement Secures A$1.37 millionPRICE SENSITIVE18/01/18
POH Phosphagenics Receipt of R&D Tax IncentivePRICE SENSITIVE17/01/18
POH Phosphagenics Announces Results of Dairy TrialPRICE SENSITIVE22/12/17
POH TPM Improves Negative Effects of Heat Stress in PoultryPRICE SENSITIVE15/12/17
POH Phosphagenics Multinational License for TPM in Personal CarePRICE SENSITIVE04/12/17
POH Phosphagenics Update on TPM/Propofol Development ProgramPRICE SENSITIVE09/11/17
POH Phosphagenics Entitlement Offer Information BookletPRICE SENSITIVE03/10/17
POH Phosphagenics Announces Equity RaisingPRICE SENSITIVE26/09/17
POH Phosphagenics Signs Term Sheet TPM Diclofenac Gel in AsiaPRICE SENSITIVE26/09/17
POH Trading HaltPRICE SENSITIVE22/09/17
POH Phosphagenics Market Update - Potential Return of CapitalPRICE SENSITIVE01/09/17
POH June 2017 Half-year Financial Report and Appendix 4DPRICE SENSITIVE31/08/17
POH Phosphagenics Signs Patch Development Agreement with TerumoPRICE SENSITIVE22/08/17
POH Phosphagenics Sells BioElixia Brand to Pure Beauty AustraliaPRICE SENSITIVE10/08/17
POH POH Mylan Arbitration Update- Expert Report on Damages FiledPRICE SENSITIVE29/05/17
POH Phosphagenics and IAH Cease All PartnershipsPRICE SENSITIVE09/03/17
POH Receipt of R&D Tax IncentivePRICE SENSITIVE01/03/17
POH Appendix 4E and Annual Financial ReportPRICE SENSITIVE28/02/17
POH Phosphagenics Non-Binding Term Sheet for OxyM Patch in JapanPRICE SENSITIVE31/01/17
POH Phosphagenics Poultry Feed Study Reports Positive DataPRICE SENSITIVE15/12/16
POH Reformulation TPM/Oxymorphone CompletePRICE SENSITIVE12/12/16
POH Phosphagenics ProPhase Arbitration Ruling Handed DownPRICE SENSITIVE16/11/16
POH Response to ASX Price Query-POH.AX PRICE SENSITIVE23/09/16
POH Phosphagenics Updates Long Term Incentive Scheme-POH.AX PRICE SENSITIVE12/09/16
POH Phosphagenics Begins Feed Efficiency Study in Poultry-POH.AX PRICE SENSITIVE31/08/16
POH June 2016 Half-year Financial Report and Appendix 4D-POH.AX PRICE SENSITIVE28/08/16
POH June 2016 Half-year Financial Report and Appendix 4D-POH.AX PRICE SENSITIVE26/08/16
POH Phosphagenics Completes Grower/Finisher Pig Study-POH.AX PRICE SENSITIVE30/06/16
POH Phosphagenics Initiates Cattle Study-POH.AX PRICE SENSITIVE01/06/16
POH Phosphagenics Expands Licence Agreement for Diclofenac Gel-POH.AX PRICE SENSITIVE18/05/16
POH Phosphagenics Expands Japanese Option to Oxycodone Patch-POH.AX PRICE SENSITIVE17/05/16
POH Phosphagenics Signs Japanese License Option and R&D Alliance-POH.AX PRICE SENSITIVE29/04/16
POH Receipt of $2.4m R&D Tax IncentivePRICE SENSITIVE29/03/16
POH Appendix 4E and Annual Financial ReportPRICE SENSITIVE29/02/16
POH Phosphagenics Announces Results of TPM/Oxycodone Ph2a TrialPRICE SENSITIVE29/01/16
POH Positive Results for Weaner Pig Feed Efficiency TrialPRICE SENSITIVE20/01/16
POH Response to ASX Price QueryPRICE SENSITIVE05/01/16
POH Phosphagenics' PHN Trial Completes Enrolment and DosingPRICE SENSITIVE17/12/15
POH Phosphagenics Initiates Grower/Finisher Pig StudyPRICE SENSITIVE03/12/15
POH Receipt of R&D Tax IncentivePRICE SENSITIVE11/11/15
POH Development Agreement for TPM Oxymorphone PatchPRICE SENSITIVE22/10/15
POH Phosphagenics RestructuresPRICE SENSITIVE12/10/15
POH Phosphagenics Begins Animal Health & Nutrition ProgramPRICE SENSITIVE28/09/15
POH June 2015 Half-year Appendix 4D and Financial reportPRICE SENSITIVE31/08/15
POH Oxymorphone Patch Program UpdatePRICE SENSITIVE14/05/15
POH POH Oxycodone Patch Dosing in Phase 2 Clinical TrialPRICE SENSITIVE17/04/15
POH Animal Health Nutrition License Agreement signedPRICE SENSITIVE25/03/15
POH Response to ASX Price QueryPRICE SENSITIVE12/03/15
POH December 2014 Preliminary Final Report and Financial ReportPRICE SENSITIVE26/02/15
POH POH Decides to Put its BioElixia Cosmetic Brand Up For SalePRICE SENSITIVE25/02/15
POH Phosphagenics Appoints Dr Ross Murdoch as CEOPRICE SENSITIVE14/01/15
POH Ethics Approval -Topical Phase 2 TPM Oxycodone Patch TrialPRICE SENSITIVE08/12/14
POH Successful Results -Phase 2 TPM Trentinoin Gel Study on AcnePRICE SENSITIVE07/10/14
POH June 2014 App 4D Half Yearly Report and Financial ReportPRICE SENSITIVE27/08/14
POH First IND Enabling Study for TPM Oxymorphone CompletedPRICE SENSITIVE11/08/14
POH Opioid Patch Program UpdatePRICE SENSITIVE28/07/14
POH Phosphagenics $19.3 million Capital raisingPRICE SENSITIVE11/07/14
POH Trading HaltPRICE SENSITIVE09/07/14
POHPOH Topical Oxycodone Patch Alleviates Pain in RacehorsesPRICE SENSITIVE21/05/14
POHEnrolments Completed for Phase 2 Acne Treatment TrialPRICE SENSITIVE23/04/14
POHDecember 2013 Appendix 4E - Annual Financial ReportPRICE SENSITIVE28/02/14
POHNovartis Launches Voveran TPM Gel in IndiaPRICE SENSITIVE21/01/14
POHPhosphagenics - TPM in Dairy Feed Inclusion TechnologyPRICE SENSITIVE12/12/13
POHPOH Signs Further Deed of Settlement with Final PartiesPRICE SENSITIVE08/11/13
POHPhosphagenics Signs Deed of Settlement with Dr OgruPRICE SENSITIVE30/10/13
POHPhosphagenics' Oxymorphone Patch SuccessPRICE SENSITIVE24/10/13
POHOxymorphone Pain Relief Patch - Multi-Dose TrialPRICE SENSITIVE19/09/13
POHJune 2013 Appendix 4D Half Year Financial Report - AccountsPRICE SENSITIVE30/08/13
POHPhosphagenics Pain Program UpdatePRICE SENSITIVE26/07/13
POHInvoicing and Accounting Misappropriations InvestigationPRICE SENSITIVE24/07/13
POHPhosphagenics to Launch Phase 2 Acne Treatment TrialPRICE SENSITIVE12/07/13
POHInvoicing and Accounting IrregularitiesPRICE SENSITIVE01/07/13
POHTrading HaltPRICE SENSITIVE28/06/13
POHR & D Taxation IncentivePRICE SENSITIVE28/05/13
POHPOH signs Agreement with Agricultural Research ServicePRICE SENSITIVE14/05/13
POHTPM/Diclofenac Gel - Themis in Supply Agmt with NovartisPRICE SENSITIVE15/04/13
POHOxymorphone Patch Meets Phase 1 End PointsPRICE SENSITIVE25/03/13
POHPhosphagenics Further Expands Pain PortfolioPRICE SENSITIVE20/02/13
POHDecember 2012 Appendix 4E and Audited Financial ReportPRICE SENSITIVE19/02/13
POHOxycodone Patch UpdatePRICE SENSITIVE11/02/13
POHPOH Initiates Clinical Program with Oxymorphone TPM PatchPRICE SENSITIVE16/01/13
POHPhosphagenics to Supply Firming Cream to GNCPRICE SENSITIVE05/12/12
POHOxycodone Patch Update - Development and Product ExpansionPRICE SENSITIVE03/12/12
POHPOH in JV to Supply TPM Equine Supplements to Golbal MarketPRICE SENSITIVE31/10/12
POH Changes to Leadership Team
27/03/19PRICE SENSITIVE
POH Appendix 4E - Preliminary Final Report
28/02/19PRICE SENSITIVE
POH FDA meeting provides guidance for TPM/Oxymorphone patch
17/01/19PRICE SENSITIVE
POH Reinstatement to Offical Quotation
19/12/18PRICE SENSITIVE
POH Phosphagenics and Mylan Agree Settlement
19/12/18PRICE SENSITIVE
POH Suspension from Official Quotation
12/12/18PRICE SENSITIVE
POH Trading Halt
10/12/18PRICE SENSITIVE
POH Phosphagenics Arbitration Award Issued
12/11/18PRICE SENSITIVE
POH Receipt of R&D Tax Incentive
08/11/18PRICE SENSITIVE
POH Response to ASX Price Query
26/10/18PRICE SENSITIVE
POH Phosphagenics Receives Further Arbitration Process Update
23/10/18PRICE SENSITIVE
POH Phosphagenics Licensing Agreement Update
10/09/18PRICE SENSITIVE
POH Half Year Accounts
13/08/18PRICE SENSITIVE
POH AGM Chairman's Address and CEO Presentation
25/05/18PRICE SENSITIVE download Created with Sketch. 720.65KB
POH Terumo Shifts Focus From Oxymorphone Patch to Injectables
20/03/18PRICE SENSITIVE
POH Preliminary Final Report
28/02/18PRICE SENSITIVE
POH Phosphagenics Placement Secures A$1.37 million
18/01/18PRICE SENSITIVE
POH Phosphagenics Receipt of R&D Tax Incentive
17/01/18PRICE SENSITIVE
POH Phosphagenics Announces Results of Dairy Trial
22/12/17PRICE SENSITIVE
POH TPM Improves Negative Effects of Heat Stress in Poultry
15/12/17PRICE SENSITIVE
POH Phosphagenics Multinational License for TPM in Personal Care
04/12/17PRICE SENSITIVE
POH Phosphagenics Update on TPM/Propofol Development Program
09/11/17PRICE SENSITIVE
POH Phosphagenics Entitlement Offer Information Booklet
03/10/17PRICE SENSITIVE
POH Phosphagenics Announces Equity Raising
26/09/17PRICE SENSITIVE
POH Phosphagenics Signs Term Sheet TPM Diclofenac Gel in Asia
26/09/17PRICE SENSITIVE
POH Trading Halt
22/09/17PRICE SENSITIVE
POH Phosphagenics Market Update - Potential Return of Capital
01/09/17PRICE SENSITIVE
POH June 2017 Half-year Financial Report and Appendix 4D
31/08/17PRICE SENSITIVE
POH Phosphagenics Signs Patch Development Agreement with Terumo
22/08/17PRICE SENSITIVE
POH Phosphagenics Sells BioElixia Brand to Pure Beauty Australia
10/08/17PRICE SENSITIVE
POH POH Mylan Arbitration Update- Expert Report on Damages Filed
29/05/17PRICE SENSITIVE
POH Phosphagenics and IAH Cease All Partnerships
09/03/17PRICE SENSITIVE
POH Receipt of R&D Tax Incentive
01/03/17PRICE SENSITIVE
POH Appendix 4E and Annual Financial Report
28/02/17PRICE SENSITIVE
POH Phosphagenics Non-Binding Term Sheet for OxyM Patch in Japan
31/01/17PRICE SENSITIVE
POH Phosphagenics Poultry Feed Study Reports Positive Data
15/12/16PRICE SENSITIVE
POH Reformulation TPM/Oxymorphone Complete
12/12/16PRICE SENSITIVE
POH Phosphagenics ProPhase Arbitration Ruling Handed Down
16/11/16PRICE SENSITIVE
POH Response to ASX Price Query-POH.AX
23/09/16PRICE SENSITIVE
POH Phosphagenics Updates Long Term Incentive Scheme-POH.AX
12/09/16PRICE SENSITIVE
POH Phosphagenics Begins Feed Efficiency Study in Poultry-POH.AX
31/08/16PRICE SENSITIVE
POH June 2016 Half-year Financial Report and Appendix 4D-POH.AX
28/08/16PRICE SENSITIVE
POH June 2016 Half-year Financial Report and Appendix 4D-POH.AX
26/08/16PRICE SENSITIVE
POH Phosphagenics Completes Grower/Finisher Pig Study-POH.AX
30/06/16PRICE SENSITIVE
POH Phosphagenics Initiates Cattle Study-POH.AX
01/06/16PRICE SENSITIVE
POH Phosphagenics Expands Licence Agreement for Diclofenac Gel-POH.AX
18/05/16PRICE SENSITIVE
POH Phosphagenics Expands Japanese Option to Oxycodone Patch-POH.AX
17/05/16PRICE SENSITIVE
POH Phosphagenics Signs Japanese License Option and R&D Alliance-POH.AX
29/04/16PRICE SENSITIVE
POH Receipt of $2.4m R&D Tax Incentive
29/03/16PRICE SENSITIVE
POH Appendix 4E and Annual Financial Report
29/02/16PRICE SENSITIVE
POH Phosphagenics Announces Results of TPM/Oxycodone Ph2a Trial
29/01/16PRICE SENSITIVE
POH Positive Results for Weaner Pig Feed Efficiency Trial
20/01/16PRICE SENSITIVE
POH Response to ASX Price Query
05/01/16PRICE SENSITIVE
POH Phosphagenics' PHN Trial Completes Enrolment and Dosing
17/12/15PRICE SENSITIVE
POH Phosphagenics Initiates Grower/Finisher Pig Study
03/12/15PRICE SENSITIVE
POH Receipt of R&D Tax Incentive
11/11/15PRICE SENSITIVE
POH Development Agreement for TPM Oxymorphone Patch
22/10/15PRICE SENSITIVE
POH Phosphagenics Restructures
12/10/15PRICE SENSITIVE
POH Phosphagenics Begins Animal Health & Nutrition Program
28/09/15PRICE SENSITIVE
POH June 2015 Half-year Appendix 4D and Financial report
31/08/15PRICE SENSITIVE
POH Oxymorphone Patch Program Update
14/05/15PRICE SENSITIVE
POH POH Oxycodone Patch Dosing in Phase 2 Clinical Trial
17/04/15PRICE SENSITIVE
POH Animal Health Nutrition License Agreement signed
25/03/15PRICE SENSITIVE
POH Response to ASX Price Query
12/03/15PRICE SENSITIVE
POH December 2014 Preliminary Final Report and Financial Report
26/02/15PRICE SENSITIVE
POH POH Decides to Put its BioElixia Cosmetic Brand Up For Sale
25/02/15PRICE SENSITIVE
POH Phosphagenics Appoints Dr Ross Murdoch as CEO
14/01/15PRICE SENSITIVE
POH Ethics Approval -Topical Phase 2 TPM Oxycodone Patch Trial
08/12/14PRICE SENSITIVE
POH Successful Results -Phase 2 TPM Trentinoin Gel Study on Acne
07/10/14PRICE SENSITIVE
POH June 2014 App 4D Half Yearly Report and Financial Report
27/08/14PRICE SENSITIVE
POH First IND Enabling Study for TPM Oxymorphone Completed
11/08/14PRICE SENSITIVE
POH Opioid Patch Program Update
28/07/14PRICE SENSITIVE
POH Phosphagenics $19.3 million Capital raising
11/07/14PRICE SENSITIVE
POH Trading Halt
09/07/14PRICE SENSITIVE
POHPOH Topical Oxycodone Patch Alleviates Pain in Racehorses
21/05/14PRICE SENSITIVE
POHEnrolments Completed for Phase 2 Acne Treatment Trial
23/04/14PRICE SENSITIVE
POHDecember 2013 Appendix 4E - Annual Financial Report
28/02/14PRICE SENSITIVE
POHNovartis Launches Voveran TPM Gel in India
21/01/14PRICE SENSITIVE
POHPhosphagenics - TPM in Dairy Feed Inclusion Technology
12/12/13PRICE SENSITIVE
POHPOH Signs Further Deed of Settlement with Final Parties
08/11/13PRICE SENSITIVE
POHPhosphagenics Signs Deed of Settlement with Dr Ogru
30/10/13PRICE SENSITIVE
POHPhosphagenics' Oxymorphone Patch Success
24/10/13PRICE SENSITIVE
POHOxymorphone Pain Relief Patch - Multi-Dose Trial
19/09/13PRICE SENSITIVE
POHJune 2013 Appendix 4D Half Year Financial Report - Accounts
30/08/13PRICE SENSITIVE
POHPhosphagenics Pain Program Update
26/07/13PRICE SENSITIVE
POHInvoicing and Accounting Misappropriations Investigation
24/07/13PRICE SENSITIVE
POHPhosphagenics to Launch Phase 2 Acne Treatment Trial
12/07/13PRICE SENSITIVE
POHInvoicing and Accounting Irregularities
01/07/13PRICE SENSITIVE
POHTrading Halt
28/06/13PRICE SENSITIVE
POHR & D Taxation Incentive
28/05/13PRICE SENSITIVE
POHPOH signs Agreement with Agricultural Research Service
14/05/13PRICE SENSITIVE
POHTPM/Diclofenac Gel - Themis in Supply Agmt with Novartis
15/04/13PRICE SENSITIVE
POHOxymorphone Patch Meets Phase 1 End Points
25/03/13PRICE SENSITIVE
POHPhosphagenics Further Expands Pain Portfolio
20/02/13PRICE SENSITIVE
POHDecember 2012 Appendix 4E and Audited Financial Report
19/02/13PRICE SENSITIVE
POHOxycodone Patch Update
11/02/13PRICE SENSITIVE
POHPOH Initiates Clinical Program with Oxymorphone TPM Patch
16/01/13PRICE SENSITIVE
POHPhosphagenics to Supply Firming Cream to GNC
05/12/12PRICE SENSITIVE
POHOxycodone Patch Update - Development and Product Expansion
03/12/12PRICE SENSITIVE
POHPOH in JV to Supply TPM Equine Supplements to Golbal Market
31/10/12PRICE SENSITIVE
refresh Created with Sketch. REFRESH
 
(20min delay)
Last
0.0¢ 		Change
0.000(0.00%) 		Mkt cap ! n/a
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0
POH (ASX) Chart

Top Stories

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

Who the MinRes Board has decided to move on faster may or may not be amusing, depending on how much you've lost.
Chaos reigns markets – so let's take stock of where we're at ahead of December For many people, it feels like the world has been getting crazier each year since 2020 (or 2016.) It's likely to continue
This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game Today, one small pill holds the potential to transform cognitive medicine by addressing conditions like depression and Alzheimer’s. 
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025 Samples among the highest-ever-graded uranium soil samples recorded in mineral exploration history, and an imminent drill run.
Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects Pan Asia Metals has scored $35 million from a New York private equity firm at the same time as the company's big rebrand push begins.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.